Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)

Y. H. Ling, T. Li, Z. Yuan, M. Haigentz, T. K. Weber, R. Perez-Soler

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27<sup>KIP1</sup> Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G<sub>1</sub>/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)'. Together they form a unique fingerprint.